• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物无机化学在癌症中突变型 p53 复活中的作用。

A role for bioinorganic chemistry in the reactivation of mutant p53 in cancer.

机构信息

Department of Chemistry, Simon Fraser University, Burnaby, BC, V5A 1S6, Canada.

Inserm UMR_S1113, IRFAC, team Streinth, Strasbourg University, Strasbourg, France.

出版信息

J Biol Inorg Chem. 2022 Aug;27(4-5):393-403. doi: 10.1007/s00775-022-01939-2. Epub 2022 Apr 30.

DOI:10.1007/s00775-022-01939-2
PMID:35488931
Abstract

Metal ion dysregulation has been implicated in a number of diseases from neurodegeneration to cancer. While defective metal ion transport mechanisms are known to cause specific diseases of genetic origin, the role of metal dysregulation in many diseases has yet to be elucidated due to the complicated function (both good and bad!) of metal ions in the body. A breakdown in metal ion speciation can manifest in several ways from increased reactive oxygen species (ROS) generation to an increase in protein misfolding and aggregation. In this review, we will discuss the role of Zn in the proper function of the p53 protein in cancer. The p53 protein plays a critical role in the prevention of genome mutations via initiation of apoptosis, DNA repair, cell cycle arrest, anti-angiogenesis, and senescence pathways to avoid propagation of damaged cells. p53 is the most frequently mutated protein in cancer and almost all cancers exhibit malfunction along the p53 pathway. Thus, there has been considerable effort dedicated to restoring normal p53 expression and activity to mutant p53. This includes understanding the relative populations of the Zn-bound and Zn-free p53 in wild-type and mutant forms, and the development of metallochaperones to re-populate the Zn binding site to restore mutant p53 activity. Parallels will be made to the development of multifunctional metal binding agents for modulating the aggregation of the amyloid-beta peptide in Alzheimer's Disease (AD).

摘要

金属离子失调与许多疾病有关,从神经退行性疾病到癌症。虽然已知金属离子转运机制缺陷会导致特定的遗传来源疾病,但由于金属离子在体内的复杂功能(既有好处也有坏处!),金属失调在许多疾病中的作用仍有待阐明。金属离子形态的破坏可能以多种方式表现出来,从增加活性氧(ROS)的产生到增加蛋白质错误折叠和聚集。在这篇综述中,我们将讨论 Zn 在癌症中 p53 蛋白正常功能中的作用。p53 蛋白通过启动细胞凋亡、DNA 修复、细胞周期阻滞、抗血管生成和衰老途径,在防止基因组突变方面发挥着关键作用,以避免受损细胞的传播。p53 是癌症中突变最频繁的蛋白,几乎所有癌症都表现出 p53 途径的功能障碍。因此,人们做出了相当大的努力来恢复突变型 p53 的正常 p53 表达和活性。这包括了解 Zn 结合和 Zn 游离 p53 在野生型和突变型中的相对群体,以及开发金属伴侣来重新填充 Zn 结合位点以恢复突变型 p53 活性。将与多功能金属结合剂的开发进行对比,以调节阿尔茨海默病(AD)中淀粉样β肽的聚集。

相似文献

1
A role for bioinorganic chemistry in the reactivation of mutant p53 in cancer.生物无机化学在癌症中突变型 p53 复活中的作用。
J Biol Inorg Chem. 2022 Aug;27(4-5):393-403. doi: 10.1007/s00775-022-01939-2. Epub 2022 Apr 30.
2
Altering relative metal-binding affinities in multifunctional Metallochaperones for mutant p53 reactivation.改变多功能金属伴侣蛋白中与突变 p53 再激活相关的相对金属结合亲和力。
J Inorg Biochem. 2024 Feb;251:112433. doi: 10.1016/j.jinorgbio.2023.112433. Epub 2023 Nov 22.
3
Reactivating mutant p53 using small molecules as zinc metallochaperones: awakening a sleeping giant in cancer.利用小分子作为锌金属伴侣激活突变型p53:唤醒癌症中的沉睡巨头。
Drug Discov Today. 2015 Nov;20(11):1391-7. doi: 10.1016/j.drudis.2015.07.006. Epub 2015 Jul 20.
4
Thiosemicarbazones Functioning as Zinc Metallochaperones to Reactivate Mutant p53.作为锌金属伴侣发挥作用以重新激活突变型p53的硫代氨基脲类化合物。
Mol Pharmacol. 2017 Jun;91(6):567-575. doi: 10.1124/mol.116.107409. Epub 2017 Mar 20.
5
Multifunctional metallochaperone modifications for targeting subsite cavities in mutant p53-Y220C.针对突变 p53-Y220C 亚基腔的多功能金属伴侣修饰。
J Inorg Biochem. 2023 May;242:112164. doi: 10.1016/j.jinorgbio.2023.112164. Epub 2023 Feb 21.
6
Combinatorial Therapy of Zinc Metallochaperones with Mutant p53 Reactivation and Diminished Copper Binding.锌金属伴侣蛋白与突变 p53 再激活和减少铜结合的组合疗法。
Mol Cancer Ther. 2019 Aug;18(8):1355-1365. doi: 10.1158/1535-7163.MCT-18-1080. Epub 2019 Jun 13.
7
Inhibition of p53 protein aggregation as a cancer treatment strategy.抑制 p53 蛋白聚集作为癌症治疗策略。
Curr Opin Chem Biol. 2023 Feb;72:102230. doi: 10.1016/j.cbpa.2022.102230. Epub 2022 Nov 24.
8
Small molecule restoration of wildtype structure and function of mutant p53 using a novel zinc-metallochaperone based mechanism.利用一种基于新型锌金属伴侣的机制,小分子恢复突变型p53的野生型结构和功能。
Oncotarget. 2014 Oct 15;5(19):8879-92. doi: 10.18632/oncotarget.2432.
9
Synthetic metallochaperone ZMC1 rescues mutant p53 conformation by transporting zinc into cells as an ionophore.合成金属伴侣ZMC1作为离子载体将锌转运到细胞中,从而挽救突变型p53的构象。
Mol Pharmacol. 2015 May;87(5):825-31. doi: 10.1124/mol.114.097550. Epub 2015 Feb 20.
10
Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs.锌恢复 p53 活性构象可提高突变型 p53 肿瘤细胞对抗癌药物的反应。
Cell Cycle. 2011 May 15;10(10):1679-89. doi: 10.4161/cc.10.10.15642.

引用本文的文献

1
Covalent Modification of p53 by ()-1-(4-Methylpiperazin-1-yl)-3-(5-nitrofuran-2-yl)prop-2-en-1-one.()-1-(4-甲基哌嗪-1-基)-3-(5-硝基呋喃-2-基)丙-2-烯-1-酮对p53的共价修饰
ACS Pharmacol Transl Sci. 2024 Oct 14;7(11):3559-3572. doi: 10.1021/acsptsci.4c00447. eCollection 2024 Nov 8.
2
Targeting p53 misfolding conundrum by stabilizing agents and their analogs in breast cancer therapy: a comprehensive computational analysis.通过稳定剂及其类似物解决乳腺癌治疗中p53错误折叠难题:全面的计算分析
Front Pharmacol. 2024 Jan 10;14:1333447. doi: 10.3389/fphar.2023.1333447. eCollection 2023.
3
Alzheimer's Disease and Cancer: Common Targets.

本文引用的文献

1
Copper induces cell death by targeting lipoylated TCA cycle proteins.铜通过靶向脂酰化 TCA 循环蛋白诱导细胞死亡。
Science. 2022 Mar 18;375(6586):1254-1261. doi: 10.1126/science.abf0529. Epub 2022 Mar 17.
2
Rational Multitargeted Drug Design Strategy from the Perspective of a Medicinal Chemist.从药物化学家的角度看合理的多靶点药物设计策略。
J Med Chem. 2021 Aug 12;64(15):10581-10605. doi: 10.1021/acs.jmedchem.1c00683. Epub 2021 Jul 27.
3
Multiple reactivities of flavonoids towards pathological elements in Alzheimer's disease: structure-activity relationship.
阿尔茨海默病与癌症:共同靶点
Mini Rev Med Chem. 2024;24(10):983-1000. doi: 10.2174/0113895575263108231031132404.
4
P53 Suppressor Gene Tissue Microarray-based Protein Expression Analysis in Meningiomas.基于 P53 抑癌基因组织微阵列的脑膜瘤蛋白表达分析。
In Vivo. 2022 Sep-Oct;36(5):2205-2210. doi: 10.21873/invivo.12946.
5
Letter from the editor.编辑来信。
J Biol Inorg Chem. 2022 Aug;27(4-5):391-392. doi: 10.1007/s00775-022-01951-6.
黄酮类化合物对阿尔茨海默病病理因素的多重反应性:构效关系
Chem Sci. 2020 Sep 8;11(37):10243-10254. doi: 10.1039/d0sc02046j.
4
Dietary Phytochemicals in Zinc Homeostasis: A Strategy for Prostate Cancer Management.锌稳态中的膳食植物化学物质:前列腺癌管理策略
Nutrients. 2021 May 30;13(6):1867. doi: 10.3390/nu13061867.
5
Deletion of in Cerebellar Granule Cells Impairs Synaptic Development and Motor Performance.小脑颗粒细胞中[具体内容缺失]的缺失会损害突触发育和运动表现。
Front Cell Dev Biol. 2021 Feb 25;8:627146. doi: 10.3389/fcell.2020.627146. eCollection 2020.
6
Benzothiazolyl and Benzoxazolyl Hydrazones Function as Zinc Metallochaperones to Reactivate Mutant p53.苯并噻唑基和苯并恶唑基腙作为锌金属载体蛋白,可使突变型 p53 重新激活。
J Med Chem. 2021 Feb 25;64(4):2024-2045. doi: 10.1021/acs.jmedchem.0c01360. Epub 2021 Feb 4.
7
Zinc shapes the folding landscape of p53 and establishes a pathway for reactivating structurally diverse cancer mutants.锌塑造了 p53 的折叠景观,并为激活结构多样的癌症突变体建立了一条途径。
Elife. 2020 Dec 2;9:e61487. doi: 10.7554/eLife.61487.
8
A balancing act: using small molecules for therapeutic intervention of the p53 pathway in cancer.平衡之举:利用小分子药物干预癌症中的 p53 通路
Chem Soc Rev. 2020 Oct 5;49(19):6995-7014. doi: 10.1039/d0cs00163e.
9
The p53/MDM2/MDMX-targeted therapies-a clinical synopsis.靶向p53/MDM2/MDMX的疗法——临床概述
Cell Death Dis. 2020 Apr 17;11(4):237. doi: 10.1038/s41419-020-2445-9.
10
Bifunctional ligand design for modulating mutant p53 aggregation in cancer.用于调节癌症中突变型p53聚集的双功能配体设计
Chem Sci. 2019 Oct 7;10(46):10802-10814. doi: 10.1039/c9sc04151f. eCollection 2019 Dec 14.